Specific targeting of tumor endothelial cells by a shiga-like toxin-vascular endothelial growth factor fusion protein as a novel treatment strategy for pancreatic cancer. [electronic resource]
Producer: 20110203Description: 797-806 p. digitalISSN:- 1476-5586
- Adenocarcinoma -- metabolism
- Animals
- Antimetabolites, Antineoplastic -- therapeutic use
- Blotting, Western
- Cell Movement
- Cell Proliferation
- Cells, Cultured
- Combined Modality Therapy
- Deoxycytidine -- analogs & derivatives
- Disease Models, Animal
- Endothelium, Vascular -- cytology
- Humans
- Immunoenzyme Techniques
- Male
- Mice
- Mice, Nude
- Neoplasm Metastasis
- Neovascularization, Pathologic -- prevention & control
- Pancreatic Neoplasms -- metabolism
- RNA, Messenger -- genetics
- Recombinant Fusion Proteins -- metabolism
- Reverse Transcriptase Polymerase Chain Reaction
- Shiga Toxins -- genetics
- Signal Transduction
- Survival Rate
- Vascular Endothelial Growth Factor A -- genetics
- Vascular Endothelial Growth Factor Receptor-2 -- antagonists & inhibitors
- Xenograft Model Antitumor Assays
- Gemcitabine
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.